GHK-CU Encyclopedia — Scientific Background

What Is GHK-Cu?

GHK-Cu (CAS 89030-95-5), also known as copper tripeptide-1 or copper glycyl-histidyl-lysine, is a naturally occurring human tripeptide (glycyl-L-histidyl-L-lysine) complexed with copper(II). It is chemically characterized by the molecular formula C₁₄H₂₂CuN₆O₄ and a molecular weight of 401.91 g/mol. GHK-Cu was first isolated from human plasma and is also found in saliva and urine. The peptide is present in human plasma, saliva, and urine but declines with age; levels in young adults average approximately 200 ng/mL, while by age 60 they are only about 80 ng/mL.

Mechanisms of Action

Collagen and Elastin Synthesis

GHK-Cu is a potent stimulator of collagen synthesis in fibroblast cultures. The peptide increases protein synthesis of collagen and elastin, and the presence of a GHK triplet in the α2(I) chain of type I collagen suggests that the tripeptide might be liberated by proteases at the site of a wound and exert in situ healing effects. Gene expression studies demonstrate that GHK-Cu elicits in vitro, dose-dependent transcriptional alterations in pathways relevant to extracellular matrix composition, with downregulation of genes involved in collagen fibril assembly and upregulation of genes involved in adherens junctions and cell division.

Matrix Remodeling

GHK-Cu stimulates both synthesis and breakdown of collagen and glycosaminoglycans and modulates the activity of both metalloproteinases and their inhibitors. It stimulates collagen, dermatan sulfate, chondroitin sulfate, and the small proteoglycan decorin. This balanced regulation of matrix synthesis and degradation is critical for tissue remodeling and repair.

Antioxidant Activity — Superoxide Dismutase-Like Activity

GHK-Cu possesses significant superoxide dismutase-like activity with a rate constant of about 25% of the activity of enzymatic Cu,Zn-superoxide dismutase. This antioxidant activity protects cells from oxidative damage and complements its tissue-remodeling functions.

Elastase Inhibition

Studies confirm that GHK-Cu did not significantly affect tyrosinase activity but led to 48.90 ± 2.50% elastase inhibition, supporting its role in maintaining skin elasticity and preventing degradation of the extracellular matrix.

Wound Healing and Tissue Repair

Preclinical and mechanistic literature suggests GHK-Cu may influence processes relevant to wound healing, matrix remodeling, inflammation, redox regulation, angiogenesis, and tissue repair. A Phase 2 randomized, double-blind, vehicle-controlled split-wound study (NCT07437586) is currently evaluating whether a topical gel containing GHK-Cu can safely speed up healing of small, standardized skin wounds in healthy adults.

The Bioavailability Challenge

Despite its broad biological activities, native GHK-Cu presents significant formulation challenges. GHK-Cu is a fairly hydrophilic compound with limited permeation through the lipophilic stratum corneum. The peptide is susceptible to enzymatic degradation by carboxypeptidases found in wound environments and plasma, and this rapid breakdown significantly reduces the amount of active peptide reaching the target tissue.

liposomal encapsulation addresses these limitations through a phospholipid bilayer that protects GHK-Cu from enzymatic degradation, enhances its permeation through the skin barrier, and facilitates efficient cellular delivery to fibroblasts and connective tissue cells.

Liposomal GHK-Cu

Liposomal encapsulation of GHK-Cu provides a fundamentally different delivery mechanism from conventional forms. The phospholipid bilayer surrounds the GHK-Cu molecule, forming a shield that protects it from enzymatic degradation and enhances skin permeation. This delivery system:

• Protects GHK-Cu from enzymatic degradation by carboxypeptidases

• Enhances permeation through the lipophilic stratum corneum

• Provides targeted delivery to fibroblasts and connective tissue cells

• Demonstrates excellent antioxidant and anti-inflammatory capacity

Rigid-flexible nanocarriers loaded with GHK-Cu (GHK-Cu@LP) have been developed by combining liposome technology with the classical Chinese concept of rigidity and flexibility. The research comprehensively assessed the enzymatic resistance, skin permeability, and in vitro safety of GHK-Cu@LP. Liposomes containing GHK-Cu have been prepared using various methods, with optimized formulations achieving particle sizes of approximately 117.2 nm with high homogeneity.

Clinical Evidence

Photoaging — Randomized Controlled Trial

A randomized controlled trial (Leyden 2002) in 67 women with photoaging evaluated GHK-Cu cream over 12 weeks and demonstrated improved fine lines and skin density versus placebo. A separate study (Finkley 2005) showed stimulation of collagen synthesis in skin biopsies.

Eyebrow Hair Growth

A newly identified 2026 randomized, double-blind, vehicle-controlled split-face study in 18 healthy participants reported that a 2% GHK-Cu serum improved eyebrow hair count and diameter over 12 weeks without serious adverse effects.

Skin Anti-Aging — Population Test

A 21-day population antiwrinkle efficacy test was conducted on 15 volunteers using a GHK-Cu formulation. The VISIA skin detector showed that GHK-Cu/BMA exhibited excellent clinical efficacy in antioxidant, antiwrinkle, moisturizing, and repairing activities.

Wound Healing — Ongoing Phase 2 Trial

The CuHeal trial (NCT07437586) is a Phase 2, randomized, double-blind, vehicle-controlled, split-wound study of topical GHK-Cu gel to accelerate re-epithelialization of standardized acute skin wounds in healthy adults. Participants receive two small punch-biopsy wounds on the upper arm; each wound is randomly assigned to receive GHK-Cu gel or vehicle gel under identical dressings. Wounds are photographed and assessed over 3 weeks.

Skin Permeation Enhancement

Studies demonstrate that skin absorption of GHK was increased by copper ion (Cu²⁺) and palmitic acid, and skin absorption of wrinkle improvement peptides was enhanced by cell-penetrating peptides. In cases where cell-penetrating peptides R4 and R6 were added to GHK-Cu liposomes, the final cumulative permeations in 24 hours were 15.46% and 8.64%, respectively, compared to 7.4% for GHK-Cu liposomes alone.

Safety and Regulatory

GHK-Cu is generally well tolerated. The peptide is naturally occurring in the human body and has a favorable safety profile. However, GHK-Cu exhibits a biphasic dose response—the concentrations that stimulate at low levels can be cytotoxic at high ones, so appropriate dosing is essential. Potential concerns with topical use include skin irritation, redness, or sensitivity. Overdosing of copper, especially in those who may ingest or inject GHK-Cu as a supplement, can lead to copper toxicity, which can cause multi-organ failure and neurologic impairment.

GHK-Cu is widely commercialized as a cosmetic ingredient and dietary supplement ingredient. In Australia, unapproved peptide products that are not included in the Australian Register of Therapeutic Goods have not been evaluated by the TGA for safety, quality, or effectiveness; these can include products containing GHK-Cu. In the United States, GHK-Cu is used in cosmetic formulations and is available as a research peptide. Testing protocols must adhere to international standards including USP, European Pharmacopoeia, and FAO/WHO Codex Alimentarius. Formulators should verify local regulatory requirements prior to market entry.

This product is intended for research, nutraceutical, and functional food applications. Not intended to diagnose, treat, cure, or prevent any disease.

2899$/KG

2199$/KG